In November 2021, the European Securities and Markets Authority (ESMA) published a consultation on its report on highly liquid financial instruments with regards to the investment policy of central counterparties. In this consultation, ESMA reviews whether the current, fairly restrictive list of investment options for central counterparties (CCPs) should be extended. The report contains a very thorough analysis of regulation and CCP practices in other jurisdictions and proposes some extension of the range of investments available to a CCP, for instance debt issued by the EU but also consults about including corporate debt. On money market funds, ESMA is more careful and proposes for now not to allow these funds.
ISDA members are very supportive of some of the extension of investments available to the CCP and propose to be less prescriptive but to give the CCP and its governance forums including supervisors more leeway. In the response, we also support the inclusion of public debt constant net asset value money market funds, which had significant inflows during the crisis in 2020.
Please find below the ISDA response.
Documents (1) for ISDA Responds to ESMA on Eligible CCP Investments
Latest
SwapsInfo H1 2026 & Q2 2026 Review
Trading activity in interest rate derivatives (IRD) and credit derivatives increased in the first half of 2026 compared with the same period in 2025. Growth in IRD was driven by overnight index swaps (OIS), while higher index credit derivatives activity...
ISDA In Review – July 2026
A compendium of links to new documents, research papers, press releases and comment letters published by ISDA in July 2026.
ISDA Expands SwapsInfo with US FX Derivatives Data
ISDA has expanded its SwapsInfo website to include data on US-reported foreign exchange (FX) derivatives, further increasing transparency in the over-the-counter (OTC) derivatives market. The new FX section provides insights into trading activity in FX forwards, swaps and options. Users...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.
